Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model. Int. J. Environ. Sci. [Internet]. 2025 Jun. 18 [cited 2026 Mar. 15];11(12s):1360-7. Available from: https://theaspd.com/index.php/ijes/article/view/2559